Back to Results
First PageMeta Content
Bacterial diseases / Staphylococcaceae / Antibiotic-resistant bacteria / Eli Lilly and Company / Linezolid / Vancomycin / Methicillin-resistant Staphylococcus aureus / Staphylococcus aureus / MRSE / Bacteria / Microbiology / Biology


Study 31, Methicillin-Resistant Staphylococcus Aureus (MRSA) SYNOPSIS Name of Company: Pharmacia & Upjohn Name of Finished Product:
Add to Reading List

Document Date: 2000-03-23 04:08:33


Open Document

File Size: 48,10 KB

Share Result on Facebook

Company

Within Body Systems / Pharmacia / /

Continent

Asia / North America / Europe / /

IndustryTerm

infection site / Test product / linezolid protocol / /

MedicalCondition

untreated hyperthyroidism / Insomnia / LYMPHATIC Anemia / pneumonia / MRSS infections / DIGESTIVE Constipation / bacteremia / CNS infections / Respiratory Failure / Headache / active infection / uncontrolled hypertension / urinary tract infection / Staphylococcus infection / MRSS infection / osteomyelitis / CARDIOVASCULAR Congestive Heart Failure / nausea / methicillin-resistant Staphylococcus species infections / skin and soft tissue infection / Thrombocytopenia / documented MRSS infections / Fever / Kidney Failure / pheochromocytoma / carcinoid syndrome / MRSE infections / endocarditis / chronic care facilities / diarrhea / DIGESTIVE Diarrhea / infection / RESPIRATORY Dyspnea / Thrombosis / liver disease / methicillinresistant Staphylococcus species infections / Rash / Species (MRSS) Infections / Pharyngitis / Sepsis / Hypotension / /

Position

Investigator / /

Product

Linezolid / /

PublishedMedium

Health Economics / Baseline / /

Region

Latin America / /

Technology

linezolid protocol / /

SocialTag